ClinicalTrials.Veeva

Menu
Amnova Clinical Research | Irvine, CA logo

Amnova Clinical Research | Irvine, CA

Research site

Site insights

Top conditions

Top treatments

BPN14770
JZP258-407
Cannabidiol
Ecopipam Hydrochloride
MRM-3379
Xywav
ZYN002
Selnoflast

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Contact this site

Maggie Wang

Verified by this site

Active trials

5 of 11 total trials

A Study Evaluating the Efficacy and Safety of Xywav Expanded Dosing vs Placebo in Participants With Narcolepsy or IH (XYRISE)

The purpose of this study is to evaluate the efficacy and safety of expanded Xywav dosing regimens in adult participants with narcolepsy or idiopathi...

Enrolling
Idiopathic Hypersomnia
Narcolepsy
Other: Placebo
Drug: Xywav

The main purpose of the study is to evaluate the efficacy of selnoflast compared with placebo in participants with atherosclerosis, at high-risk for...

Enrolling
Atherosclerosis
Drug: Selnoflast
Drug: Placebo

This is a 4-year, open-label extension (OLE) study for subjects completing one of two double-blind clinical trials with BPN14770, Study BPN14770-CNS-...

Active, not recruiting
Fragile X Syndrome
Drug: Zatolmilast/ BPN14770

ZYN002 is a pharmaceutically manufactured Cannabidiol that is developed as a clear gel that can be applied to the skin (called transdermal delivery)....

Active, not recruiting
Fragile X Syndrome
Drug: ZYN002 - Cannabidiol Transdermal Gel

This study is a multicenter, double-blind, randomized, placebo-controlled study to assess the safety and tolerability of 3 doses of MRM-3379 in male...

Enrolling
Fragile X Syndrome
Drug: Low dose of MRM-3379 Open-Label
Drug: Middle Dose of MRM-3379

Trial sponsors

T
Jazz Pharmaceuticals logo
E
Genentech logo
Mirum Pharmaceuticals logo
Z
H
P

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems